Keyphrases
Proteomics
100%
Neuroblastoma
100%
Anaplastic Lymphoma Kinase
100%
IRS2
100%
Cell Survival
100%
ALK Inhibitor
23%
Neuroblastoma Cells
23%
Forkhead Box O3 (FOXO3)
15%
Interactome
15%
Adaptor Protein
15%
Tyrosine Kinase Inhibitor
7%
Proteomic Strategy
7%
Kinase Cascade
7%
Proteome
7%
Therapy Resistance
7%
Network Rewiring
7%
Mass Spectrometry Analysis
7%
Phosphoproteomics
7%
Tyrosine Kinase Inhibitor Treatment
7%
Phosphorylation
7%
Future Therapies
7%
Multiple Signalling
7%
Crizotinib
7%
Quantitative Mass Spectrometry
7%
Oncogenic Signaling
7%
Druggable Targets
7%
Kinase Target
7%
Proteomic Analysis
7%
Neuroblastoma Cell Line
7%
Clinically Significant
7%
Downstream Targets
7%
Phosphotyrosine
7%
Signaling Axis
7%
Tyrosine Phosphorylation
7%
Small Interfering RNA (siRNA)
7%
Kinase Signaling
7%
Signaling Adaptors
7%
Transcription Factor
7%
Biochemistry, Genetics and Molecular Biology
Insulin Receptor
100%
Proteomics
100%
Anaplastic Lymphoma Kinase
100%
Cell Survival
100%
Tyrosine Kinase Inhibitor
31%
Interactome
12%
Protein Kinase B
12%
Proteome
6%
Mass Spectrometry
6%
Phosphoproteome
6%
Transcription Factor
6%
Tyrosine Phosphorylation
6%
Small Interfering RNA
6%
Medicine and Dentistry
Insulin Receptor Substrate 2
100%
Interactome
12%
Ceritinib
6%
Phosphoproteome
6%
5 Chloro 4 [[2 (Isopropylsulfonyl)phenyl]amino] 2 [[2 Methoxy 4 [4 (4 Methyl 1 Piperazinyl) 1 Piperidinyl]phenyl]amino]pyrimidine
6%
Lorlatinib
6%